HuntDiseaseFAQS

Family history and DNA analysis in HD
Home
Index
GENETIC TESTING INFO
EARLY HD
MEDICATIONS~DRUGS
Movement Disorder Medicines
Anxiety-Antidepressant Medications
Antidepressant Adverse Effects
Warnings~Adolescents Under 25
Sertraline ~Zoloft
SSRI's
Anti-psychotic Medications
Prozac, Luvox, Paxil, Zoloft & Celexa
Olanzipine & Risperidone and blood tests
Creatine
Drugs~General
Cutting Prescriptions
Sites That Help the Medicine Go Down
Vitamins & Minerals
SYMPTOMS
Why Certain Symptoms Occur In HD
Tests Commonly Used -Neuropsychological Examination
Symptom vs Medication
HD-Disability
HD~Communications
Speech & Swallowing Difficulties~Lynn Rhodes
Swallowing Problem Warning Signs
Swallowing Tests
Nutrition and HD~Anna Gaba (Recipes)
HD & Diet~HSA Fact Sheet 7
HD~Swallowing & Nutrition
Weight Gain
Taste
5 Levels Difficulty In Swallowing
Feeding Tube~Advanced Stages of HD
Feeding Tube~Jean Miller
One more word on feeding tubes
PEG Tubes and baby foods
Feeding Tubes-More Info
Dehydration
HD~Chorea
HD~Falling/Safety Issues
HD~Cognitive/Decision Making/Impulsivity
Cognitive-Short Tips
HD-Apathy
HD~Perceptual/Unawareness/Attention
Denial of HD
HD~Irritability/Temper Outbursts
Managing behavioral problems
HD~Depression
Depression - Treatment Resistant Patient
HD~Anxiety/Apathy/Irritability
HD~Mania, Obsessive Disorders
HD~Hallucinations & Psychosis
HD~Rigidity, Spasticity, and Dystonia
HD~Seizure/Convulsion/Epilepsy/Tics
Nails
MISCELLANEOUS
Adaptive Products
HD~Suicide
Teen Suicide~Let's Talk Facts
HD~Incontinence
Stress Explained-Easy/Fun Format
How To Help Someone Chronically Ill
Legal Planning for Incapacity
Out-of-Home Care Options FAQ
Preparing for Emergencies
 "Because prevalence studies have been based on this type
of information, the data suggest an underestimation of the
prevalence of Huntington's disease in the community of 14%."
 
Family history and DNA analysis in patients
with suspected Huntington's disease
Abstract

OBJECTIVES
Until recently a definite diagnosis of Huntington's disease could be made by a combination of clinical findings, a positive family history, and pathological confirmation. Prevalence data are based on these criteria. After finding the gene and its pathogenic mutation direct diagnostic confirmation became available.

The aim of this study was to determine to what extent the direct assessment of CAG repeat length has allowed the diagnoses of additional patients, with atypical psychiatric or neurological disease, or those without a family history, that could otherwise not be diagnosed using traditional criteria.

PATIENTS AND METHODS
From all 191 referred patients suspected of having Huntington's disease between July 1993 and January 1996 CAG repeat length was determined and the family history was reviewed in the Leiden roster.

After a retrospective search the patients were subdivided in positive, negative, suspect, and unknown family histories. Patients with an expanded repeat (>35) were finally diagnosed as having Huntington's disease. The family history was compared with the repeat length and the clinical features.

RESULTS
Clinical information was obtained for 172 patients. Of these, 126 patients had an expanded repeat, 77 had a positive, eight a negative, 40 a suspect, and one an unknown family history.
 
Of the 44 patients with a normal repeat length four had a positive family history. Of the two patients with an intermediate repeat (between 30-36 repeats), one with a negative family history received a clinical diagnosis of Gilles de la Tourette's syndrome. The other had an unknown family
 
CONCLUSION
Despite verification of the family history through the Leiden roster, many more patients and families could be diagnosed with the new approach than would have been possible with the traditional criteria. Because prevalence studies have been based on this type of information, the data suggest an underestimation of the prevalence of Huntington's disease in the community of 14%.

(J Neurol Neurosurg Psychiatry 2000;69:54-59)
S Sieslinga, M Vegter-van de Vlisb, M Losekootb c, R D M Belfroidc,
J A Maat-Kievitb, H P H Kremerd, R A C Roosaa Department of Neurology, K5Q-112 Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands, Centre for Clinical Genetics, cDepartment of Human Genetics, Department of Neurology, Radboud Hospital, Nijmegen, The Netherlands. Correspondence to: Professor R A C Roos R.A.C.Roos@LUMC.NL
 
Source:  J Neurol Neurosurg Psychiatry 2000;69:54-59 ( July )  Article